Human fibrinogen/Human coagulation factor XIII

N/A

Report date: 2024/07/03 09:30:17

Base Information

Drug NameHuman fibrinogen/Human coagulation factor XIII
Drug Alias NameHuman fibrinogen/Human coagulation factor XIII/Bovine aprotinin/Human thrombin/Calcium chlorideBeriplast-P
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionFibrinogen replacementsThrombin replacements
TargetsFibrinogen
Therapy Area/IndicationsWounds and InjuriesHemorrhage
Global Approved IndicationsWounds and InjuriesHemorrhage
Approved Indications in ChinaN/A
Original Approved Country/TerritoryFrance
Original Approved Date2000/04/01
Country/TerritoryFrance
CombinationsYes
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsWounds and InjuriesHemorrhage
Inactive IndicationsN/A

Other Information

ATC CodeB02BC
Related LinksN/A